Impact of SARS CoV-2 in hemoglobinopathies: a protective mechanism being from Beta chain Hemoglobin defects? SARS-CoV-2 and Hemoglobinopathies

Main Article Content

Lorenza Torti
Laura Maffei
Francesco Sorrentino
Paolo De Fabritiis
Rossella Miceli
Elisabetta Abruzzese


SARS-CoV-2, thalassemia;, hemoglobinopathies;, infection;, epidemiology


Not required for Letters


Download data is not yet available.

Abstract 1139
PDF Downloads 707
HTML Downloads 315



1. Galimberti S, Baldini C, Baratè C, Ricci F, Balducci S, Grassi S,et al. The CoV-2 outbreak: how hematologists could help to fight Covid-19. Pharmacol Res. 2020 May 6:104866. doi: 10.1016/j.phrs.2020.104866. https://doi: 10.1016/j.phrs.2020.104866. Epub 2020 May 6.PMID: 32387301
2. Groneberg D, Hilgenfeld R, Zabel P. Molecular mechanisms of severe acute respiratory syndrome (SARS). Respiratory Research volume 6, Article number: 8 (2005) .https:// doi: 10.1186/1465-9921-6-8. PMID: 15661082
3. Menachery VD, Mitchell HD, Cockrell AS, Gralinski LE, Yount BL Jr, Graham RL, et al. MERS-CoV Accessory ORFs Play Key Role for Infection and Pathogenesis. mBio. 2017 Aug 22;8(4).https:// doi: 10.1128/mBio.00665-17.
4. Liu W, Hualan L. COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism. ChemRxiv March 2020.
5. Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020 Mar 26. pii: S0923-7534(20)36383-3. https://doi: 10.1016/j.annonc.2020.03.296.
6. Seisdedos B, Gil D, Blouin, J.-M., E. & Millet, O. Protein Homeostasis Diseases .389-413.(Elsevier, 2020).
7. Vento S, Cainelli F, Cesario F. Infections and thalassemia. Lancet Infect Dis 2006,6:226-33. PMID: 16554247 https://DOI: 10.1016/S1473-3099(06)70437-6 .

8. Tahir F, Ahmed J, Malik F. Post-splenectomy Sepsis: A Review of the Literature. Cureus. 2020;12(2):e6898. 2020 Feb 6. https://doi:10.7759/cureus.6898.
9. Roy NBA, Telfer P, Eleftheriou P, de la Fuente J, Drasar E, Shah F, et al. National Haemoglobinopathy Panel. Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemic. Br J Haematol. 2020 Apr 24. https://doi: 10.1111/bjh.16687.
10. De Sanctis V, Kattamis C, Canatan D, Soliman A, Elsedfy H, Karimi M, et al. ?-Thalassemia Distribution in the Old World: an Ancient Disease Seen from a Historical Standpoint. MJHID 2017;9; e2017018. PMID:28293406
https://DOI: 10.4084/MJHID.2017.018
11. Silvestroni E, Bianco I. New statistical study on microcythemia in certain parts of the province of Ferrara and in the province of Rovigo. Prog Med (Napoli). 1952 Dec 31;8(24):760-3.
12. Piel FB, Steinberg MH, Rees DC. Sickle Cell Disease. N Engl J Med. 2017 Apr 20;376(16):1561-1573.https:// doi: 10.1056/NEJMc1706325. PMID: 28723338
13. Web Reference: For this statistic, numbers reported by Johns Hopkins University have been compared with the latest available population numbers.
14. Rivieccio BA, Luconi E, Boracchi P, Pariani E, Romanò L, Salini S, Castaldi S, Biganzoli E, Galli M. Heterogeneity of COVID-19 outbreak in Italy. Acta Bio Med [Internet]. 2020Apr.20 [cited 2020May15];91(2):31. PMID: 32420921 https://DOI: 10.23750/abm.v91i2.9579
15. Karimi M, Haghpanah S, Azarkeivan A, Zahedi Z, Zarei T, Akhavan Tavakoli M, Bazrafshan A, Shirkavand A, De Sanctis V. Prevalence and Mortality due to Outbreak of Novel Coronavirus Disease (COVID-19) in ?-Thalassemias: The Nationwide Iranian Experience. Br J Haematol. 2020;10.1111/bjh.16911. https://doi:10.1111/bjh.16911
16. Lansiaux E., Pebay P, Picard JL and Son-Forget J. COVID-19: Beta-Thalassemia Subjects Immunised?. Med Hypotheses. 2020 May 12;142:109827. PMCID: PMC7217120
https://DOI: 10.1016/j.mehy.2020.109827